New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1
Overview
Affiliations
Natural-killer group 2 member D (NKG2D) is a well-characterized activating receptor expressed by natural killer (NK) cells, NKT cells, activated CD8 T cells, subsets of γδ T cells, and innate-like T cells. NKG2D recognizes multiple ligands (NKG2D-ligands) to mount an innate immune response against stressed, transformed, or infected cells. NKG2D-ligand surface expression is tightly restricted on healthy cells through transcriptional and post-transcriptional mechanisms, while transformed or infected cells express the ligands as a danger signal. Recent studies have revealed that unfolded protein response pathways during endoplasmic reticulum (ER) stress result in upregulation of ULBP-related protein the protein kinase RNA-like ER kinase-activating factor 4-C/EBP homologous protein (PERK-ATF4-CHOP) pathway, which can be linked to the pathogenesis of autoimmune diseases. Transformed cells, however, possess mechanisms to escape NKG2D-mediated immune surveillance, such as upregulation of carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1), a negative regulator of NKG2D-ligands. In this review, we discuss mechanisms of NKG2D-ligand regulation, with a focus on newly discovered mechanisms that promote NKG2D-ligand expression on epithelial cells, including ER stress, and mechanisms that suppress NKG2D-ligand-mediated killing of cancer cells, namely by co-expression of CEACAM1.
Alles M, Demberg T, Liyanage N Curr Opin HIV AIDS. 2025; 20(2):145-153.
PMID: 39774039 PMC: 11802316. DOI: 10.1097/COH.0000000000000913.
Drug resistance and tumor immune microenvironment: An overview of current understandings (Review).
Liu Y, Liang J, Zhang Y, Guo Q Int J Oncol. 2024; 65(4).
PMID: 39219258 PMC: 11387120. DOI: 10.3892/ijo.2024.5684.
Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT.
Zhong S, Zhang Y, Mou H, Jian C, Huang Q, Ou Y Aging (Albany NY). 2024; 16(3):2789-2811.
PMID: 38319715 PMC: 10911341. DOI: 10.18632/aging.205511.
The Unfolded Protein Response at the Tumor-Immune Interface.
Zanetti M, Xian S, Dosset M, Carter H Front Immunol. 2022; 13:823157.
PMID: 35237269 PMC: 8882736. DOI: 10.3389/fimmu.2022.823157.
Moratalla A, Solorio Y, Lemaitre F, Farzam-Kia N, Levert A, Zandee S Neurol Neuroimmunol Neuroinflamm. 2021; 9(1).
PMID: 34873031 PMC: 8656234. DOI: 10.1212/NXI.0000000000001119.